Abstract 1064: Pellino-1: A Novel Candidate In Vegf/Flk-1/MKK2 Signaling In Ischemic Preconditioning Induced Cardioprotection: A Study Using Flk +/− and MKK2 −/− Knockout Mice.

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Mahesh Thirunavukkarasu ◽  
Samson Mathews Samuel ◽  
Sankar Addya ◽  
Lijun Zhan ◽  
Chi-Kuang Huang ◽  
...  
Keyword(s):  
Real Time ◽  
Ischemic Preconditioning ◽  
Knockout Mice ◽  
Real Time Pcr ◽  
Left Ventricular ◽  
List Type ◽  
Mrna Levels ◽  
Clinical Issue ◽  
Endothelial Cell Function ◽  
Vegf Signaling

VEGF modulates the complex process of angiogenesis and other various aspects of endothelial cell function through either of its two tyrosine kinase receptors, VEGFR1/Flt-1 or VEGFR2/Flk1/ KDR via its target protein MKK2. In the present study we used Flk1 +/− and MKK2 −/− knockout mice in an attempt to address an important clinical issue by identifying potential downstream candidates of VEGF signaling through Flk1 receptor that trigger cardioprotective signal during ischemic preconditioning (IP). Mouse hearts were subjected to 30 min of global ischemia and 2 hours of reperfusion (IR) in the Isolated Working Heart model. It is known that IP (4min of ischemia + 6min reperfusion, 4 cycles, before 30 min of ischemia) induces cardioprotection through the activation of the VEGF signaling cascade. The mice were randomly divided into 6 groups for both the gene knockout (KO) studies: Wild Type-Baseline (WTBL), FlkBL/ MKK2BL (KOBL), WTIR , KOIR, WTIP and KOIP. Significant reduction in left ventricular functional recovery through out reperfusion (dp/dt = 605 vs 884), diminished coronary flow (1.9 vs 2.4) and aortic flow (0.16 vs 1.2) and increased infarct size (38.4% vs. 28.41%) after reperfusion were observed in FlkIR, compared to WTIR. As expected we observed disruption in IP induced cardioprotection in FlkIP compared to WTIP. Affymetrix gene chip analysis demonstrated significant downregulation of genes (Pellino-1, MKK2, NF-ΰB) which are thought to play important roles in cardioprotection after ischemic insults in the Flk +/− mice compared to WT. These results were further validated at the mRNA expression level with Real Time PCR. Pellino-1 (Pel-1) was found to be significantly downregulated in FlkBL (0.74 vs 1), FlkIR (1.29 vs 1.35) and FlkPC (1.35 vs 1.49) as compared to their respective controls. We further validated the mRNA levels of Pel-1using Real Time PCR and RT-PCR in the MKK2 −/− mice and found that it, remained unaffected in MKK2BL as compared to its WTBL, and increased as expected in MKK2PC as compared to both MKK2BL and FlkPC (2.48 vs 1.2 and 2.48 vs 1.35, respectively). Therefore this study validated for the first time that Pel-1 is a novel downstream mediator in VEGF/FLK1 signaling and it induces IP mediated cardioprotection via MKK2 signaling.

Abstract 5564: Sequencial Activation of VEGF/Flk-1/MKK2/NFkappaB Signaling in Ischemic Preconditioning Induced Neovascularization: A Study with Flk-1+/− and MKK2−/− Knockout Mice

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Mahesh Thirunavukkarasu ◽  
Yozu Akita ◽  
Samson Mathews Samuel ◽  
Lijun Zhan ◽  
Chi-Kuang Huang ◽  
...  
Keyword(s):  
Ischemic Preconditioning ◽  
Knockout Mice ◽  
Immunohistochemical Analysis ◽  
Capillary Density ◽  
Regulation Of Transcription ◽  
Clinical Issue ◽  
Vegf Signaling ◽  
Shift Analysis ◽  
First Time ◽  
Fractional Shortening

Ischemic preconditioning mediated activation of VEGF-FLK-1-MKK2/NFkappaB pathway identifies these components as a critical regulator of myocardial angiogenesis in an infarcted myocardium. In the present study we used Flk-1+/− and MKK2−/− knockout mice in an attempt to address and prove this important clinical issue by identifying potential downstream candidates of VEGF signaling through Flk-1 receptor that trigger angiogenic signal during ischemic preconditioning (IP). Both wild type (WT) and Flk1+/− mice were subjected to either permanent LAD ligation (MI) or Ischemic preconditioning (IP) followed by MI. Flk-1+/− mouse hearts displayed significant increase in infarct size in Flk-1+/−PCMI (46%) group as compared to WTPCMI (33%) groups. Immunohistochemical analysis demonstrated decreased capillary and arteriolar density in both Flk-1+/−MI and Flk-1+/−PCMI groups as compared to WTMI and WTPCMI. Echocardiography demonstrated significant decrease in fractional shortening ( 21% vs 28%) and ejection fraction (42% vs 54%) following 4 weeks of myocardial infarction in Flk-1+/−PCMI group as compared with WTPCMI. As expected we found Flk-1+/− resulted in disruption of the cardioprotective effect by IP compared to WT. IP induced phosphorylation of p38MAPK, MKK2 was found to be inhibited (1.8 and 2 folds) significantly in both the Flk-1+/−MI and Flk-1+/−PCMI groups by Western blot analysis. Similarly Gelshift analysis showed down regulation of transcription factor NFkappaB (2 fold) in the Flk-1+/− mice as compared to WT. We further extended our experiments to validate our data in MKK2−/− mice. Hearts were subjected to LAD ligation. After 4-days of MI BSL-lectin infusion demonstrated significant disruption of neovascularization (capillary density) in the MKK2−/−PCMI (1520 counts/mm2) group compared to the WTPCMI ( 1850 counts/mm2). Gel-shift analysis in MKK2−/−PCMI group documented reduced NFkappaB activity (1.5 fold) compared to WTPCMI (2.4 fold). Taken together, this study validated for the first time that NFkappaB is a novel downstream mediator of VEGF/FLK-1/p38MAPK-MKK2 signaling and it induces IP mediated cardioprotection and angiogenesis via MKK2 signaling.

Genome-wide screening of m6A-modified transcript in the Wilms’ tumor

2021 ◽  
Author(s):  
Zhuo Liu ◽  
Feng He ◽  
Jing Liu ◽  
Shengrong OuYang ◽  
Zexi Li ◽  
...  
Keyword(s):  
Gene Ontology ◽  
Real Time ◽  
Real Time Pcr ◽  
Wilms Tumor ◽  
Expression Patterns ◽  
Mrna Levels ◽  
Gene Ontology Analysis ◽  
Quantitative Real Time Pcr ◽  
Related Factors ◽  
Significant Difference

Abstract Background Wilms’ tumor, also called nephroblastoma, is the most common pediatric renal malignancy. The pathogenesis of Wilms’ tumor has been attributed to several genetic and epigenetic factors. However, the most pervasive internal mRNA modification that affects almost every process of RNA metabolism, RNA N6-Methyladenosine (m6A) methylation, has not been characterized in Wilms’ tumor. Methods Wilms’ tumor (WT) and adjacent non-cancerous (NC) tissue samples were obtained from 23 children with nephroblastoma, and the global m6A levels were measured by mass spectrometry. Analyses by m6A-mRNA epitranscriptomic microarray and mRNA microarray were performed, and m6A-related mRNAs were validated by quantitative real-time PCR for input and m6A-immunoprecipitated RNA samples from WT and NC tissues. Gene ontology analysis and KEGG pathway analysis were performed for differentially expressed genes, and expression of RNA methylation-related factors was measured by quantitative real-time PCR. Results The total m6A methylation levels in total RNA of WT samples and NC samples were (0.21 ± 0.01)% and (0.22 ± 0.01)%, respectively, with no statistically significant difference. Fifty-nine transcripts were differentially m6A-methylated between the WT and NC groups, which showed distinct m6A modification patterns. Gene ontology analysis indicated that m6A-modified genes were enriched in cancer-associated pathways, including the mTOR pathway, and conjoint analysis of the unique methylation and gene expression patterns in WT samples suggested an association with metabolic pathways.The mRNA levels of the m6A-related “reader” genes, YTHDF1, YTHDF2 and IGF2BP3, were statistically higher in WT samples than in NC samples. Conclusion This is the first study to determine the m6A modification profiles in Wilms’ tumor. Our data provide novel information regarding patterns of m6A modification that correlate with carcinogenesis in Wilms’ tumor.

MO332THE IRRADIATION-INDUCED RENAL ISCHEMIC PRECONDITIONING IS BLUNTED BY THE ORAL ADMINISTRATION OF THE ANTI-ANGIOGENIC AGENT, SUNITINIB

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Badr Khbouz ◽  
François Lallemand ◽  
Pascal Rowart ◽  
Laurence Poma ◽  
Agnès Noel ◽  
...  
Keyword(s):  
Signaling Pathways ◽  
Real Time ◽  
Ischemic Preconditioning ◽  
Functional Enrichment ◽  
Whole Body ◽  
Control Group ◽  
Mrna Levels ◽  
Wild Type ◽  
Post Irradiation ◽  
Real Time Qpcr

Abstract Background and Aims Whole-body irradiation has been suggested to induce renal ischemic preconditioning (RIP) in rodent models, possibly via neo-angiogenesis. First, we comprehensively investigate the pathways involved in kidney-centered irradiation. Next, we assess the functional and structural impact of kidney-centered irradiation applied before ischemia/reperfusion (I/R) injury. Finally, we test whether Sunitinib-mediated inhibition of the neo-angiogenesis prevents irradiation-associated RIP. Method Experiment 1: Unilateral irradiation of the left kidney (8.56 Gy) was performed in male 10-week-old wild-type C57bl/6 mice (n=10). One month later, total kidney RNA was extracted from irradiated and control (n=5) mice for comparative high-throughput RNA-Seq (using BaseSpace Sequence Hub Illumina). Functional enrichment analysis was performed using Database for Annotation, Visualization and Integrated Discovery (DAVID). Experiment 2: Two x-ray beams (225Kv, 13mA) specifically targeted both kidneys for a total dose of 8.56Gy. The right kidneys were removed and harvested, and the left kidneys undergo 30-minute ischemia followed by 48-hour reperfusion (n=8) at Days 7-14-21-28 post irradiation. Experiment 3: Following the same protocol of renal I/R at Day14, 3 groups of male 10-week-old wild-type C57bl/6 mice were compared (n=8 per group): 1/ bilateral pre-irradiation; 2/ bilateral pre-irradiation and gavage with Sunitinib from Day2 to Day13; 3/ control group without irradiation or gavage. Results Experiment 1: Comparative transcriptomics showed a significant up-regulation of various signaling pathways, including angiogenesis (HMOX1) and stress response (HSPA1A, HSPA1B). Expressions of angiogenesis markers (CD31, TGFb1, HMOX1) showed an increase at both mRNA (real-time qPCR) and protein (immuno-staining) levels in irradiated kidneys compared to controls (p<0.01). Experiment 2: Following I/R, the blood urea nitrogen (BUN) and serum creatinine (SCr) levels were significantly lower in the irradiated animals compared to controls: (BUN: 86.2±6.8 vs. 454.5±27.2mg/dl; SCr: 0.1±0.01 vs. 1.7±0.2mg/dl, p<0.01). The renal infiltration by CD11b-positive cells (187±32 vs. 477±20/mm²) and F4-80 macrophages (110±22 vs. 212±25/mm²) was significantly reduced in the irradiated group. The real-time qPCR mRNA levels of the angiogenic markers, TGFb1 and CD31, were significantly increased in the irradiated group compared to controls (p<0,01). The CD31-immunostating (quantified by FiJi) was increased in irradiated mice compared to controls (p<0.01). Experiment 3: One-way analysis of variance followed by Tukey’s test showed that, following I/R, the serum levels of BUN and SCr were lower in irradiated group compared to controls (BUN: 106.1±33.6 vs. 352.2±54.3mg/dl; SCr: 0.3±0.13 vs. 1±0.2mg/dl), and in irradiated group compared to the irradiated-exposed group to Sunitinib (BUN: 106.1±33.6 vs. 408.4±54.9mg/dl; SCr: 0.3±0.12 vs. 1.5±0.3mg/dl; p<0.01). No difference was observed between the irradiated-exposed mice to Sunitinib and the controls. Conclusion Renal irradiation induces the activation of signaling pathways involved in angiogenesis in mice. Renal pre-irradiation leads to RIP, with preserved renal function and attenuated inflammation post I/R. Exposure to the anti-angiogenic drug Sunitinib post-irradiation prevents the irradiation-induced RIP.

scholarly journals Cloning, Characterization, and Expression Features of Chicken CDS2 Splicing Variants

2020 ◽  
Author(s):  
Yuanyuan Xu ◽  
Shuping Zhang ◽  
Yujun Guo ◽  
Wen Chen ◽  
Yanqun Huang
Keyword(s):  
Adipose Tissue ◽  
Real Time ◽  
Real Time Pcr ◽  
Expression Patterns ◽  
Mrna Levels ◽  
Exogenous Insulin ◽  
Quantitative Real Time Pcr ◽  
Temporal Expression ◽  
Spatio Temporal ◽  
The Brain

Abstract Background: The CDS gene encodes the CDP-diacylglycerol synthase enzyme that catalyzes the formation of CDP-diacylglycerol (CDP-DAG) from phosphatidic acid. At present, there are no reports of CDS2 in birds. Here, we identified chicken CDS2 transcripts by combining conventional RT- PCR amplification, 5' RACE (Fig. 1A), and 3' RACE, explored the spatio-temporal expression profiles of total CDS2 and the longest transcript variant CDS2-4, and investigated the effect of exogenous insulin on total the mRNA level of CDS2 by quantitative real-time PCR. Results: Four transcripts of chicken CDS2 (CDS2-1, -2, -3, and -4) were identified, which were alternatively spliced at the 3′-untranslated region (UTR). CDS2 was widely expressed in all tissues examined and the longest variant CDS2-4 was the major transcript. Both total CDS2 and CDS2-4 were prominently expressed in adipose tissue and the heart, and exhibited low expression in the liver and pectoralis of 49 day-old chickens. Quantitative real-time PCR revealed that total CDS2 and CDS2-4 had different spatio-temporal expression patterns in chicken. Total CDS2 exhibited a similar temporal expression tendency with a high level in the later period of incubation (embryonic day 19 [E19] or 1-day-old) in the brain, liver, and pectoralis. While CDS2-4 presented a distinct temporal expression pattern in these tissues, CDS2-4 levels peaked at 21 days in the brain and pectoralis, while liver CDS2-4 mRNA levels were highest at the early stage of hatching (E10). Total CDS2 (P < 0.001) and CDS2-4 (P = 0.0090) mRNA levels in the liver were differentially regulated throughout development of the chicken. Exogenous insulin significantly downregulated the level of total CDS2 at 240 min in the pectoralis of Silky chickens (P < 0.01). Total CDS2 levels in the liver of Silky chickens were higher than that of the broiler in the basal state and after insulin stimulation. Conclusion: Chicken CDS2 has multiple transcripts with variation at the 3′-UTR, which was prominently expressed in adipose tissue. Total CDS2 and CDS2-4 presented distinct spatio-temporal expression patterns, and they were differentially regulated with age in liver. Insulin could regulate chicken CDS2 levels in a breed- and tissue-specific manner.

Investigation of the effect of Prunus Amygdalus Amara on the expression of some genes of apoptosis and immortality in breast cancer cells (MCF-7)

2021 ◽  
Vol 13 ◽  
Author(s):  
Maryam Abdolahi-Majd ◽  
Gholamhossein Hassanshahi ◽  
Mahboubeh Vatanparast ◽  
Mojgan Noroozi Karimabad
Keyword(s):  
Real Time ◽  
Real Time Pcr ◽  
Pcr Analysis ◽  
Mrna Levels ◽  
Prunus Amygdalus ◽  
Mcf7 Cells ◽  
Significant Difference ◽  
Anti Cancer ◽  
Bitter Almond ◽  
Mcf 7

Background: Anti-cancer effects of almond nuts or oil have been approved, but there are a few pieces of research that have evaluated, in detail, almond and other seeds' effects on cancer. Therefore, in the present project, the aim was to explore the regulatory effect of the bitter almond extract (Prunus amygdalus Batsch) on the apoptotic and anti-cancer potency of MCF-7 cells. Objectives: In the current experimental research, the Almond effect on MCF7 cells was evaluated by investigating the expression and the balance between Bcl-2, Bax genes to unmark the potential molecular mechanism. Methods: For 24 and 48h, the MCF7 cells were treated with the bitter almond extract (187.5-3000 µg/mL). MTT assay was used to assess the viability, and Real-time-PCR was applied to determine the expression of Bax and Bcl-2, facing β-actin. Results: Our results revealed a significant difference between different extract concentrations on the viability of MCF7 cell lines in 24 and 48 h; cell viability decreased time-dependently (P < 0.05). After 24 and 48h of extract facing MCF7 cells, the evaluated IC50 value was 3000 and 1500 µg/mL, respectively. Based on Real Time-PCR analysis, after 24 and 48 h, the mRNA levels of BCL-2 decreased by the extract, whereas BAX was in the MCF-7 cell line. Conclusion: From the results, it can be concluded that bitter almond extract has anti-cancer properties that may influence the apoptotic pathways by regulating relative gene expression.

scholarly journals Quantitative Real-time PCR for the Measurement of 11β-HSD1 and 11β-HSD2 mRNA Levels in Tissues of Healthy Dogs

2007 ◽  
Vol 39 (8) ◽  
pp. 548-554 ◽  
Author(s):  
N. Sieber-Ruckstuhl ◽  
M. Meli ◽  
F. Boretti ◽  
E. Gönczi ◽  
H. Lutz ◽  
...  
Keyword(s):  
Real Time ◽  
Real Time Pcr ◽  
Mrna Levels ◽  
Quantitative Real Time Pcr ◽  
Healthy Dogs

p29ING4 Regulates the Production of Pro-Angiogenic Molecules by Human Myeloma Cells in Normoxic and Hypoxic Conditions Being Involved in Myeloma-Induced Angiogenesis.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 515-515
Author(s):  
Sara Tagliaferri ◽  
Francesca Morandi ◽  
Paolo Lunghi ◽  
Simona Colla ◽  
Mirca Lazzaretti ◽  
...  
Keyword(s):  
Tumor Suppressor ◽  
Mrna Expression ◽  
Real Time ◽  
Real Time Pcr ◽  
Interleukin 8 ◽  
Mrna Levels ◽  
Quantitative Real Time Pcr ◽  
Angiogenic Switch ◽  
Hypoxic Conditions

Abstract Multiple myeloma (MM) cells produce several angiogenic molecules as VEGF, Angiopoietin-1 (Ang-1), interleukin-8 (IL-8) and osteopontin (OPN), however the molecular mechanisms underlying the angiogenic switch are not completely elucidated. The candidate tumor suppressor gene inhibitor of growth family member 4 (p29ING4) has been recently implicated in solid tumors as a repressor of angiogenesis and tumor growth through the suppression of angiogenic related molecules including interleukin-8 (IL-8) and the hypoxia inducible factor (HIF)-1 alpha. In this study we investigate the potential involvement of p29ING4 in the angiogenic switch in MM. First using quantitative real time PCR we compared p29ING4 with VEGF, Ang-1, IL-8 and OPN mRNA levels in eight human myeloma cell lines (HMCLs). A significantly negative correlation was observed between ING4 and IL-8 and a trend of correlation with OPN. Following we transfected HMCLs JJN3, OPM-2 and RPMI-8226 with specific siRNA to completely block the expression of p29ING4 checking the effect on the expression and production of the myeloma-related angiogenic molecules VEGF, Ang-1, IL-8 and OPN by quantitative real time PCR and ELISA assay. p29ING4 suppression in HMCLs did not affect VEGF and Ang-1 production but induced a strong up-regulation of IL-8 mRNA and IL-8 protein secretion. Similarly an induction of OPN mRNA expression as well as OPN secretion was induced by siRNA anti-p29ING4. Moreover conditioned media of HMCLs transfected with siRNA anti p29ING4 significantly increased vessel formation in an experimental in vitro model of angiogenesis (ANGIO kit) as compared to controls. Further we investigate the role of p29ING4 in the production of angiogenic molecule by MM cells in hypoxic condition compared to normoxic one as well as its potential relationship with HIF-1alpha system. Hypoxia induced HIF-1alpha expression at nuclear level and its activity in HMCLs and p29ING4 suppression by siRNA further induced HIF-1alpha transcriptional activity with an increase of its target gene Nip-3 in HMCLs. In turn the block of HIF1-alpha by specific siRNA up-regulated p29ING4 and suppressed IL-8 and OPN mRNA expression by HMCLs suggesting a relationship between p29ING4 and HIF-1alpha activity. These in vitro observations have been extended in vivo by the finding of a significant correlation between bone marrow (BM) plasma IL-8 levels and p29ING4 mRNA expression in purified MM cells obtained from 40 newly diagnosed MM patients (R=−0.58 Spearman’s 2-tailed test: p=0.04), consistently MM patients with higher BM IL-8 levels have a significantly lower p29ING4 mRNA levels. Similarly MM patients positive for OPN expression with high OPN BM levels had a significant lower p29ING4 levels (p=0.02). Finally we found that MM patients with high microvalscular density (MVD&gt;30) have significant lower p29ING4 levels as compared to those with low MVD (&lt;30) (p=0.04) and that MM patients with histological high grade had significant lower p29ING4 mRNA levels (Mann-Whitney 2-tailed: p=0.05). In conclusion, our data indicate that the tumor suppressor p29ING4 regulate the production of angiogenic molecules by MM cells both in normoxic and hypoxic conditions being involved in MM-induced angiogenesis and potentially in tumor progression.

Sickle RBCs Stimulate Human Monocyte Cytokine Expression.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 2255-2255
Author(s):  
Ke Xu ◽  
Marilyn J. Telen
Keyword(s):  
Real Time ◽  
Adhesion Molecules ◽  
Internal Control ◽  
Real Time Pcr ◽  
Mrna Levels ◽  
U937 Cells ◽  
Monocyte Activation ◽  
Antibody Treatment ◽  
Tnf Α ◽  
Activated State

Abstract Sickle red cells (SS RBCs) express numerous adhesion molecules, including LW, CD44, CD47, and Lutheran (LU) proteins, as well as phosphatidylserine. Proadhesive SS RBCs bind to endothelial cells, leading to their activation. Sickle monocytes have also been shown to express increased surface CD11b, as well as the cytokines tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β), indicating their activated state. Chronic inflammation and high plasma levels of IL-1β can stimulate leukocyte proliferation and leukocytosis. An association between leukocytosis and increased morbidity and mortality of sickle cell disease (SCD) has been observed. However, the mechanism of monocyte activation in SCD is still unknown. We therefore sought to determine if SS RBCs played a role in monocyte activation. Blood samples were obtained from six normal adult volunteers, and SS RBCs were obtained from 12 adult patients homozygous for hemoglobin S. Plasma and buffy coat were removed, and 6 μl of SS RBCs were washed with sterile phosphate-buffered saline. After incubation with one million cells of the human promonocytic cell line U937 for 2 hours at 37°C, RBCs were lysed and total U937 RNA was isolated. Following reverse transcription, real-time PCR was performed using 200 nM primers for IL-1β, IL-6 or TNF-α, 50 ng cDNA and 12.5 μl of SYBR green 2× Super Mix in a 25 μl reaction volume. The amplification reaction was carried out over 40 cycles (10 min at 95°C, followed by a two-step cycling program of 15s at 95°C and 30s at 60°C). GAPDH was analyzed in parallel as an internal control. IL-1β, IL-6 and TNF-α U937 mRNA was significantly up-regulated after incubation with SS RBCs vs incubation with normal RBCs (relative to control without RBCs, relative mRNA levels: IL-1β: 2.77 ± 1.79 vs 0.82 ± 0.19, p=0.012; IL-6: 2.17 ± 0.94 vs 0.74 ± 0.34, p=0.003; and TNF-α: 3.01 ± 1.30 vs 1.09 ± 0.17, p=0.003). To identify the adhesion molecules involved in the interaction between SS RBCs and monocytes, 10 μg/ml soluble recombinant Lutheran (srLU) was incubated with U937 cells at 37°C for 2h. After incubation, total RNA was isolated from untreated and treated U937 cells. Real time PCR results showed that srLU treatment activated U937 cell TNF-α expression, (relative mRNA level 1.63 ± 0.02 vs 1.00 ± 0.01, p&lt;0.0001, n=3) but not IL-1β or IL-6 expression (relative mRNA levels sLU treated vs untreated control, n=3-IL-1β: 1.24 ± 0.09 vs 1.00 ± 0.02, p=0.07; IL-6: 1.35 ± 0.30 vs 1.00 ± 0.01, p = 0.31). Neither soluble LW nor soluble CD44 had a similar effect. To verify that LU was involved in the interaction between SS RBCs and monocytes, inhibition assays were also performed. SS RBCs were incubated with anti-LU Ab for 1 h at 4°C to block RBC surface LU before incubation with U937 cells. Data from five paired treated and untreated samples showed decreased TNF-α mRNA expression after anti-LU antibody treatment (1.16 ± 0.14 vs 1.40 ± 0.12, p=0.005). Overall, these data suggest that monocytes can be activated by cell-cell interactions with SS RBCs to express the cytokines IL-1β, IL-6 and TNF-α. This activation is at least partially mediated through SS RBC Lutheran protein, which is over-expressed by these cells and is known to bind to leukocyte α4β1 integrin. These studies thus reveal that intact SS RBCs likely play a direct role in monocyte activation in SCD patients.

Effect of a new type androgen receptor antagonist, TAS3681, on ligand-independent AR activation through its AR downregulation activity.

2016 ◽  
Vol 34 (2_suppl) ◽  
pp. 199-199 ◽  
Author(s):  
Daisuke Kajiwara ◽  
Kazuhisa Minamiguchi ◽  
Masanao Seki ◽  
Hiroya Mizutani ◽  
Hiroki Aoyagi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Growth Factor ◽  
Real Time ◽  
Real Time Pcr ◽  
Target Gene ◽  
Mrna Levels ◽  
Castration Resistant Prostate Cancer ◽  
Protein Levels ◽  
Androgen Independent

199 Background: Two new therapies, enzalutamide and abiraterone, directed at the androgen receptor (AR) signaling axis, represent important advances in the management of castration-resistant prostate cancer (CRPC). However, eventually almost all of patients acquire resistance to these drugs by a variety of mechanisms. Ligand independent AR activation such as induction of AR splice variants and AR overexpression are major issues of current CRPC progression. In the present study, we report the biological characterization of TAS3681, which is a new AR antagonist with AR downregulation activity, and propose this concept as a potential new approach for the treatment of CRPC. Methods: For assay of AR transactivation, prostate cancer (PCa) cells were transiently transfected with androgen-responsive reporter gene construct. The transfected cells were treated with growth factor and cytokine in steroid-depleted media, and luciferase activity was measured. To evaluate the effect of TAS3681 on AR and c-Myc protein expression, PCa cells were treated with TAS3681 in steroid-depleted media. AR and c-Myc protein levels were determined by western blot. Real-time PCR was used to analyze the mRNA levels of c-Myc and c-Myc target gene. Chromatin immunoprecipitation was performed to determine the enrichment of AR at the element. Results: TAS3681 dose-dependently reduced AR protein levels in PCa cells. In contrast to enzalutamide, TAS3681 suppressed androgen-independent AR transactivation by growth factor and cytokine. In PCa cells which express full-length AR and splice variant AR-v7, TAS3681 suppressed AR-v7 target gene expression through downregulation of AR-v7. Moreover, TAS3681 reduced expression of c-Myc, critical driver of androgen-independent mechanisms of PCa progression, via AR downregulation activity. In addition, real-time PCR assay showed the transcriptional suppression of c-Myc and its target gene by TAS3681. Conclusions: TAS3681 exhibits suppressive effects on ligand-independent AR activation via AR decreasing activity. These finding suggest that TAS3681 could be a candidate of breakthrough therapy for resistance to current AR pathway target drugs.

scholarly journals Stabilization of circulating thyroglobulin mRNA transcripts in patients treated for differentiated thyroid carcinoma

2016 ◽  
Vol 54 (5) ◽  
pp. 558-566 ◽  
Author(s):  
Søren Feddersen ◽  
Lars Bastholt ◽  
Susanne M Pedersen
Keyword(s):  
Thyroid Carcinoma ◽  
Real Time ◽  
Real Time Pcr ◽  
Room Temperature ◽  
Differentiated Thyroid Carcinoma ◽  
Mrna Levels ◽  
Serum Thyroglobulin ◽  
Tempus Tubes ◽  
Antithyroglobulin Antibodies ◽  
Previously Treated

Background The clinical utility of serum thyroglobulin in the follow-up of patients with differentiated thyroid carcinoma may be compromised by the presence of endogenous antithyroglobulin antibodies. To prevent interference by antithyroglobulin antibodies several groups have developed real-time PCR-based assays for quantification of blood thyroglobulin mRNA levels. For accurate quantification of thyroglobulin mRNA in blood preanalytical factors must be recognized and controlled. In this study, we evaluate the effect of different blood RNA stabilizing systems – the Tempus Blood RNA system and the PAXgene Blood RNA system – and storage time on RNA yield and quality, and thyroglobulin mRNA stability. Methods Blood samples from 11 patients previously treated for differentiated thyroid carcinoma were collected in K2-EDTA, Tempus and PAXgene tubes and maintained at room temperature. RNA was isolated following storage for 0 and 72 h, and RNA yield, integrity and purity was determined. Thyroglobulin, GAPDH and ACTB mRNA levels were quantified by semi-quantitative real-time PCR. Results The RNA yield was significantly higher for blood collected in Tempus tubes compared with PAXgene tubes following storage for 72 h at room temperature ( P = 0.0011). High-quality RNA could be extracted from blood collected in PAXgene and Tempus tubes. Blood collected in K2-EDTA tubes, but not in PAXgene and Tempus tubes, showed significant changes in thyroglobulin mRNA levels following storage for 72 h at room temperature ( P = 0.0263). Conclusions Stabilization of blood in PAXgene and Tempus tubes enables storage at room temperature for up to 72 h, without compromising thyroglobulin mRNA levels.

Sign in / Sign up

Export Citation Format

Share Document